Open main menu
Search Ctrl + K
Free Trial
Loading...
G Medical Innovations Holdings Ltd.
Watch
Surgical & Medical Instruments & Apparatus
OTC.GMVDF
5 Oppenheimer St., Rehovot, L3, 7670105
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Material Contracts
EX-10.18
Financing Commitment Extension Letter To The Board Of Directors Of The Company F
from F-1
27 Jul 23
EX-10.16
Financing Commitment Extension Letter To The Board Of Directors Of The Company F
from F-1/A
24 Mar 23
EX-10.15
Financing Commitment Extension Letter To The Board Of Directors Of The Company F
from F-1/A
28 Feb 23
EX-10.1
Sales Agreement By And Between G Medical Innovations Holdings Ltd. And A.g.p./al
from 6-K
19 Sep 22
EX-10.1
Amended And Restated Convertible Debenture Dated June 1, 2022, Originally Issued
from F-3
11 Jul 22
EX-10.39
Joint Development, Licensing And Distribution Agreement Between The Company And
from F-1
31 Jan 22
EX-10.36
Securities Purchase Agreement Dated April 7, 2021, Between The Company And Jonat
from F-1/A
22 Apr 21
EX-10.37
Convertible Debenture Dated April 7, 2021 Issued By The Company To Jonathan B. R
from F-1/A
22 Apr 21
EX-10.38
Form Of Warrant Issued By The Company To Jonathan B. Rubini Under The Securities
from F-1/A
22 Apr 21
EX-10.1
from DRS/A
23 Feb 21
EX-10.2
from DRS/A
23 Feb 21
EX-10.2(1)
from DRS/A
23 Feb 21
EX-10.2(2)
from DRS/A
23 Feb 21
EX-10.3
from DRS/A
23 Feb 21
EX-10.4
from DRS/A
23 Feb 21
EX-10.5
from DRS/A
23 Feb 21
EX-10.6
from DRS/A
23 Feb 21
EX-10.7
from DRS/A
23 Feb 21
EX-10.8
from DRS/A
23 Feb 21
EX-10.9
from DRS/A
23 Feb 21
EX-10.10
from DRS/A
23 Feb 21
EX-10.11
from DRS/A
23 Feb 21
EX-10.12
from DRS/A
23 Feb 21
EX-10.13
from DRS/A
23 Feb 21
EX-10.14
from DRS/A
23 Feb 21
EX-10.15
from DRS/A
23 Feb 21
EX-10.16
from DRS/A
23 Feb 21
EX-10.17
from DRS/A
23 Feb 21
EX-10.18
from DRS/A
23 Feb 21
EX-10.19
from DRS/A
23 Feb 21
EX-10.20
from DRS/A
23 Feb 21
EX-10.21
from DRS/A
23 Feb 21
EX-10.22
from DRS/A
23 Feb 21
EX-10.23
from DRS/A
23 Feb 21
EX-10.24
from DRS/A
23 Feb 21
EX-10.25
from DRS/A
23 Feb 21
EX-10.26
from DRS/A
23 Feb 21
EX-10.27
from DRS/A
23 Feb 21
EX-10.28
from DRS/A
23 Feb 21
EX-10.29
from DRS/A
23 Feb 21
EX-10.30
from DRS/A
23 Feb 21
EX-10.31
from DRS/A
23 Feb 21
EX-10.32
from DRS/A
23 Feb 21
EX-10.1
from DRS
13 Jan 21
EX-10.2
from DRS
13 Jan 21
EX-10.2(1)
from DRS
13 Jan 21
EX-10.2(2)
from DRS
13 Jan 21
EX-10.3
from DRS
13 Jan 21
EX-10.4
from DRS
13 Jan 21
EX-10.5
from DRS
13 Jan 21
EX-10.6
from DRS
13 Jan 21
EX-10.7
from DRS
13 Jan 21
EX-10.8
from DRS
13 Jan 21
EX-10.9
from DRS
13 Jan 21
EX-10.10
from DRS
13 Jan 21
EX-10.11
from DRS
13 Jan 21
EX-10.12
from DRS
13 Jan 21
EX-10.13
from DRS
13 Jan 21
EX-10.14
from DRS
13 Jan 21
EX-10.15
from DRS
13 Jan 21
EX-10.16
from DRS
13 Jan 21
EX-10.17
from DRS
13 Jan 21
EX-10.18
from DRS
13 Jan 21
EX-10.19
from DRS
13 Jan 21
EX-10.20
from DRS
13 Jan 21
EX-10.21
from DRS
13 Jan 21
EX-10.22
from DRS
13 Jan 21
EX-10.17
Amendment To Convertible Securities Agreement, Dated August 15, 2019, By And Bet
from F-1/A
22 Oct 20
EX-10.18
Amendment To Convertible Securities Agreement, Dated November 26, 2019, By And B
from F-1/A
22 Oct 20
EX-10.19
Capital Commitment Agreement, Dated November 29, 2019 By And Between The Company
from F-1/A
22 Oct 20
EX-10.20
Deedof Termination, Settlement And Release, Dated February 2020, By And Between
from F-1/A
22 Oct 20
EX-10.21
Second Deed Of Variation, Dated April 2020, By And Between The Company, Mef I, L
from F-1/A
22 Oct 20
EX-10.22
Summarytranslation Of Loan Agreement, Dated February 25, 2019, Between Bank Mizr
from F-1/A
22 Oct 20
EX-10.23
Provider Participation Agreement, Dated April 2019, By And Between The Company A
from F-1/A
22 Oct 20
EX-10.27
Media And Marketing Services Agreement, Dated September 30, 2020, By And Between
from F-1/A
22 Oct 20
EX-10.28
Provider Participation Agreement, Dated April 2019, By And Between The Company A
from F-1/A
22 Oct 20
EX-10.29
Distribution Agreement, Dated April 20, 2020, By And Between The Company And Liv
from F-1/A
22 Oct 20
EX-10.30
Distribution Agreement, Dated April 2020, By And Between The Company And All Cou
from F-1/A
22 Oct 20
EX-10.24
from DRS/A
09 Sep 20
EX-10.25
from DRS/A
09 Sep 20
EX-10.26
from DRS/A
09 Sep 20
EX-10.1
from DRS
17 Jul 20
EX-10.2
from DRS
17 Jul 20
EX-10.2I
from DRS
17 Jul 20
EX-10.2II
from DRS
17 Jul 20
EX-10.3
from DRS
17 Jul 20
EX-10.4
from DRS
17 Jul 20
EX-10.5
from DRS
17 Jul 20
EX-10.6
from DRS
17 Jul 20
EX-10.7
from DRS
17 Jul 20
EX-10.8
from DRS
17 Jul 20
EX-10.9
from DRS
17 Jul 20
EX-10.10
from DRS
17 Jul 20
EX-10.11
from DRS
17 Jul 20
EX-10.12
from DRS
17 Jul 20
EX-10.13
from DRS
17 Jul 20
EX-10.14
from DRS
17 Jul 20
EX-10.15
from DRS
17 Jul 20
EX-10.16
from DRS
17 Jul 20
EX-10.1
Form Of Indemnification Agreement
from F-1/A
03 Jun 19
EX-10.2
G Medical Innovations Holdings Global Equity Plan
from F-1/A
03 Jun 19
EX-10.2.1
G Medical Innovations Holdings Ltd. - Israel Sub-plan
from F-1/A
03 Jun 19
EX-10.2.2
G Medical Innovations Holdings Ltd. - U.s. Sub-plan
from F-1/A
03 Jun 19
EX-10.3
Form Of Performance Rights Agreement
from F-1/A
03 Jun 19
EX-10.4
Credit Line Agreement, Dated December 6, 2015, By And Between The Company And Dr
from F-1/A
03 Jun 19
EX-10.5
Loan Agreement, Dated December 19, 2016, By And Between The Company And Dr. Yaco
from F-1/A
03 Jun 19
EX-10.6
Amendment To Loan Agreement, Dated February 26, 2017, By And Between The Company
from F-1/A
03 Jun 19
EX-10.7
Loan Agreement, Dated October 1, 2018, By And Between The Company And Dr. Yacov
from F-1/A
03 Jun 19
EX-10.8
Collateral Agency Agreement, Dated October 29, 2018, By And Between The Company
from F-1/A
03 Jun 19
EX-10.9
General Security Agreement, Dated October 29, 2018, By And Between The Company A
from F-1/A
03 Jun 19
EX-10.10
Convertible Securities Agreement, Dated October 29, 2018, By And Between The Com
from F-1/A
03 Jun 19
EX-10.11
Controlled Placement Deed, Dated September 5, 2018, By And Between The Company A
from F-1/A
03 Jun 19
EX-10.12
Controlled Placement Deed Side Letter, Dated September 5, 2018, By And Between T
from F-1/A
03 Jun 19
EX-10.13
Stock Purchase Agreement, Dated October 27, 2017, By And Between The Company And
from F-1/A
03 Jun 19
EX-10.14
Software Licensing Agreement
from F-1/A
03 Jun 19
EX-10.15
Contract For The Establishment Of Guangzhou G Medical Innovations Medical Techno
from F-1/A
03 Jun 19
EX-10.16
Amendment To Convertible Securities Agreement, Dated April 23, 2019, By And Betw
from F-1/A
03 Jun 19
EX-10.14
from DRS/A
01 Mar 19
EX-10.1
from DRS
28 Dec 18
EX-10.2
from DRS
28 Dec 18
EX-10
from DRS
28 Dec 18
EX-10
from DRS
28 Dec 18
EX-10.3
from DRS
28 Dec 18
EX-10.4
from DRS
28 Dec 18
EX-10.5
from DRS
28 Dec 18
EX-10.6
from DRS
28 Dec 18
EX-10.7
from DRS
28 Dec 18
EX-10.8
from DRS
28 Dec 18
EX-10.9
from DRS
28 Dec 18
EX-10.10
from DRS
28 Dec 18
EX-10.11
from DRS
28 Dec 18
EX-10.12
from DRS
28 Dec 18
EX-10.13
from DRS
28 Dec 18